אנסטרוזול מדיטק 1 מ"ג

País: Israel

Língua: hebraico

Origem: Ministry of Health

Ingredientes ativos:

ANASTROZOLE 1 MG

Disponível em:

SAM-ON LTD

Código ATC:

L02BG03

Forma farmacêutica:

FILM COATED TABLETS

Via de administração:

PER OS

Fabricado por:

HELM PHARMACEUTICALS GMBH, GERMANY

Grupo terapêutico:

ANASTROZOLE

Indicações terapêuticas:

Treatment of advanced breast cancer in post menopausal women. Efficay has not been demonstrated in estrogen receptor negative patients unless they had a previous positive clinical response to tamoxifen. Adjuvant treatment of postmenopausal women with hormone receptor positive early invasive breast cancer. Adjuvant treatment of early breast cancer in hormone receptor positive postmenopausal women who have received 2 to 3 years of adjuvant tamoxifen.

Data de autorização:

2011-01-01